Stockreport

NeuroSense Announces Year End 2023 Financial Results and Provides Business Update

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF CAMBRIDGE, Mass., April 5, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegener [Read more]